Inici › Limfoma difús de cèl·lules B grans › Oregon › Portland
Assaigs clínics de Limfoma difús de cèl·lules B grans a Portland, OR
15 estudis de Limfoma difús de cèl·lules B grans busquen participants en centres de Portland i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
ReclutantFase 2
- Oregon Health and Science University, Portland
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
ReclutantFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
ReclutantFase 3
- Kaiser Permanente Interstate Medical Office - Central ( Site 0181), Portland
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
ReclutantFase 2
- Providence Portland Medical Center ( Site 0120), Portland
- Providence Oncology and Hematology Clinic Westside ( Site 0179), Portland
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
ReclutantEstudi observacional
- OHSU Knight Cancer Institute, Portland
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ReclutantFase 1
- Oregon Health & Science University (OHSU), Portland
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
ReclutantFase 1/2
- Oregon Health and Science University ( Site 1004), Portland
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
ReclutantFase 2
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ReclutantFase 1/2
- Oregon Health & Science University, Portland
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
ReclutantEstudi observacional
- Oregon Health and Science University Knight Cancer Institute, Portland
DALY II USA/ MB-CART2019.1 for DLBCL
ReclutantFase 2
- Oregon Health and Science University Knight Cancer Institute, Portland
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
ReclutantFase 1/2
- OHSU Knight Cancer Institute, Portland
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ReclutantFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- i 1 més
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
ReclutantFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · a 12 mi
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
ReclutantFase 1
- Oregon Health & Science University, Portland
Assaigs de Limfoma difús de cèl·lules B grans en altres ciutats
- New York City, NY21 estudis
- Baldwin Park, CA19 estudis
- Chicago, IL18 estudis
- Houston, TX17 estudis
- Los Angeles, CA17 estudis
- Boston, MA16 estudis
- Milwaukee, WI16 estudis
- Nashville, TN15 estudis
- Philadelphia, PA15 estudis
- Durham, NC14 estudis
- Dallas, TX13 estudis
- Seattle, WA12 estudis
Altres estudis a Portland
- Càncer de pulmó de cèl·lules no petites46 estudis
- Càncer (tots els tipus)34 estudis
- Càncer de pròstata33 estudis
- Càncer de mama33 estudis
- Càncer metastàtic29 estudis
- Càncer colorrectal28 estudis
- Càncer d'ovari27 estudis
- Càncer de pulmó26 estudis
- Leucèmia mieloide aguda25 estudis
- Càncer d'endometri24 estudis
- Carcinoma de cèl·lules escamoses de cap i coll19 estudis
- Càncer de pàncrees19 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.